Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Stueland Katherine (CIK 1689575) reported 95 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-18). Recent activity: Buy WGS (18,750 shares), Sell WGS (1,648 shares), Sell WGS (148 shares), Sell WGS (1,525 shares), Sell WGS (4,141 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 18,750 | $0 |
| 2026-09-18 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 1,648 | $155,337 |
| 2026-09-18 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 148 | $14,120 |
| 2026-09-18 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 1,525 | $147,774 |
| 2026-09-18 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 4,141 | $406,936 |
| 2026-09-18 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 3,039 | $300,846 |
| 2026-09-11 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 6,547 | $0 |
| 2026-09-11 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 3,692 | $310,932 |
| 2026-06-18 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 18,750 | $0 |
| 2026-06-18 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 2,140 | $127,865 |
| 2026-06-18 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 5,932 | $360,844 |
| 2026-06-18 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 2,429 | $149,384 |
| 2026-06-11 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 6,546 | $0 |
| 2026-06-11 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 3,639 | $195,669 |
| 2026-05-01 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 3,874 | $0 |
| 2026-05-01 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 2,154 | $140,441 |
| 2026-05-01 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 18 | $1,154 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 80,000 | $0 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 13,229 | $810,805 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 5,117 | $318,943 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 13,412 | $848,711 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 5,292 | $341,863 |
| 2026-03-30 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Sell | 9,883 | $644,470 |
| 2026-03-17 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 11,921 | $0 |
| 2026-03-17 | GeneDx Holdings Corp. (WGS) | CHIEF EXECUTIVE OFFICER | Buy | 18,750 | $0 |
Source: SEC Form 4 filings · as of 2026-09-18